Ensysce Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.90 | -$0.90 | -$0.90 |
| Q2 2024 | 0 | -$0.39 | -$0.39 | -$0.39 |
| Q3 2024 | 2 | -$0.24 | -$0.10 | -$0.17 |
| Q4 2024 | 0 | -$0.17 | -$0.17 | -$0.17 |
| Q1 2025 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q2 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q3 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q4 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
Ensysce Biosciences, Inc. Earnings Date And Information
Ensysce Biosciences, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.22 earnings per share for the quarter, topping analysts' consensus estimates of $-0.39 by $0.17. The company had revenue of 181,797 for the quarter and had revenue of 2.23 M for the year. Ensysce Biosciences, Inc. has generated $-5 earnings per share over the last year ($-4.69 diluted earnings per share) and currently has a price-to-earnings ratio of -0.17. Ensysce Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Ensysce Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$0.39 | -$0.22 | 0.17 | $300,000 | $181,797 |
| 05/10/2024 | Q1 2024 | -$0.55 | $305,722 | |||
| 03/14/2024 | Q4 2023 | -$0.86 | -$1.55 | -0.69 | $515,032 | |
| 11/09/2023 | Q3 2023 | -$1.06 | -$0.87 | 0.19 | $593,333 | $435,380 |
| 08/10/2023 | Q2 2023 | -$2.73 | -$0.98 | 1.75 | $760,000 | $490,472 |
| 05/15/2023 | Q1 2023 | -$13.91 | -$1.73 | 12.18 | $789,635 | |
| 03/30/2023 | Q4 2022 | -$8.46 | $1.43 M | |||
| 11/14/2022 | Q3 2022 | -$36.01 | -$84.13 | -48.12 | $1.00 M | $279,351 |
| 08/11/2022 | Q2 2022 | -$50.42 | -$62.35 | -11.93 | $1.00 M | $207,471 |
| 05/12/2022 | Q1 2022 | -$48.02 | $25.65 | 73.67 | $603,098 | |
| 03/31/2022 | Q4 2021 | -$100.00 | $1.64 M | |||
| 11/15/2021 | Q3 2021 | -$169.83 | $1.20 M | $1.20 M | ||
| 08/16/2021 | Q2 2021 | -$13.99 | $444,516 | |||
| 06/07/2021 | Q1 2021 | -$14.40 | $250,576 | |||
| 03/15/2021 | Q4 2020 | $3.26 | $416,489 | |||
| 11/09/2020 | Q3 2020 | $23.90 | $827,639 | |||
| 08/07/2020 | Q2 2020 | -$10.72 | $1.82 M | |||
| 05/07/2020 | Q1 2020 | -$0.05 | $862,400 | |||
| 03/10/2020 | Q4 2019 | -$0.11 | $0 | |||
| 11/07/2019 | Q3 2019 | $0.08 | $0 |
Ensysce Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Ensysce Biosciences, Inc.'s earnings date?
Ensysce Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
Did Ensysce Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Ensysce Biosciences, Inc. (:ENSC) reported $-0.22 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.39 by $0.17.
-
How can I listen to Ensysce Biosciences, Inc.'s earnings conference call?
The conference call for Ensysce Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Ensysce Biosciences, Inc.'s conference call transcript?
The conference call transcript for Ensysce Biosciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Ensysce Biosciences, Inc. generate each year?
Ensysce Biosciences, Inc. (:ENSC) has a recorded annual revenue of $2.23 M.
-
How much profit does Ensysce Biosciences, Inc. generate each year?
Ensysce Biosciences, Inc. (:ENSC) has a recorded net income of $2.23 M. Ensysce Biosciences, Inc. has generated $-4.69 earnings per share over the last four quarters.
-
What is Ensysce Biosciences, Inc.'s price-to-earnings ratio?
Ensysce Biosciences, Inc. (:ENSC) has a price-to-earnings ratio of -0.17 and price/earnings-to-growth ratio is -0.
